NCT01872260 Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01871558 Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin Status COMPLETED Phase PHASE3
NCT01870778 Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF Status COMPLETED Phase PHASE3
NCT01870739 A Study to Evaluate the Effect of LCZ696 on Aortic Stiffness in Subjects With Hypertension Status COMPLETED Phase PHASE2
NCT01870726 Safety and Efficacy of INC280 and Buparlisib (BKM120) in Patients With Recurrent Glioblastoma Status TERMINATED Phase PHASE1/PHASE2
NCT01870505 BYL719 Plus Letrozole or Exemestane for Patients With Hormone-Receptor Positive Locally-Advanced Unresectable or Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT01868685 Study of Muscle Effects of BYM338 in Mechanically Ventilated Patients Status WITHDRAWN Phase PHASE2
NCT01868477 Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome. Status COMPLETED Phase PHASE2
NCT01865188 Study of the Efficacy and Safety of LCZ696 Alone and in Combination With Amlodipine in Patients With Hypertension Status WITHDRAWN Phase PHASE3
NCT01864070 Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease Status WITHDRAWN Phase PHASE1
NCT01863745 Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment Status COMPLETED Phase PHASE2
NCT01863732 Extension in AS: Sustainability of Benefits, Safety and Tolerability Status COMPLETED Phase PHASE3
NCT01862263 Effect of 13-Week Treatment With Vildagliptin as Add-On Therapy to Improve Glucose Variability in Type II Diabetes Status TERMINATED Phase PHASE4
NCT01860989 A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection Status COMPLETED Phase PHASE2
NCT01860066 A 12 Week Study of QVA149 Compared to Fluticasone/Salmeterol (Advair) for Treatment of COPD Status WITHDRAWN Phase PHASE3
NCT01859455 Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins Status COMPLETED Phase PHASE1
NCT01857193 Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer Status COMPLETED Phase PHASE1
NCT01854606 Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma Status COMPLETED Phase PHASE1
NCT01852292 Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy Status TERMINATED Phase PHASE2